Pharming Group
PHAR
17 hedge funds and large institutions have $4.26M invested in Pharming Group in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.
199% more capital invested
Capital invested by funds: $1.43M → $4.26M (+$2.84M)
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
31% more funds holding
Funds holding: 13 → 17 (+4)
3.05% more ownership
Funds ownership: 0.12% → 3.18% (+3.1%)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MACM
MAC Alpha Capital Management
Tampa,
Florida
|
+$31.1M |
| 2 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
+$180K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$25.8K |
| 4 |
SGFG
Silver Grove Financial Group
Orchard Park,
New York
|
+$15.5K |
| 5 |
Optiver Holding
Amsterdam,
Netherlands
|
+$4.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
-$46.3K |
| 2 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$28.4K |
| 3 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
-$9.27K |
| 4 |
SP
SmartHarvest Portfolios
Poulsbo,
Washington
|
-$5.53K |
| 5 |
LFG
Larson Financial Group
St Louis,
Missouri
|
-$4.87K |
PHAR Hedge Fund Activity: Q2 2026 in Review
17 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q2 2026, worth a combined $4.26M — up 199% from $1.43M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PHAR positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was MAC Alpha Capital Management, opening a new position worth an estimated $31.1M. The largest seller was Silverberg Bernstein Capital Management, cutting an estimated $46.3K.
- 17 institutional investors held Pharming Group (PHAR) as of Q2 2026, up from 13 in Q1 2026.
- Funds reported $4.26M of Pharming Group stock for Q2 2026, up 199% quarter-over-quarter.
- 7 funds opened new Pharming Group positions in Q2 2026 and 3 closed out, a net change of +4 holders.
- The largest Pharming Group buyer in Q2 2026 was MAC Alpha Capital Management, an estimated $31.1M added.
- The largest Pharming Group seller in Q2 2026 was Silverberg Bernstein Capital Management, an estimated $46.3K sold.
Based on aggregated 13F filings for Q2 2026.